title: [Dyslipidemia and stroke in patients with chronic kidney disease].
abstract: Altered lipid and lipoprotein metabolism occurs in patients with chronic kidney disease (CKD). Dyslipidemia persists in patients on chronic hemodialysis orperitoneal dialysis and even in renal transplant recipients, and contributes to accelerated atherosclerosis but may also contribute to the progression of kidney disease as well. The etiologies of altered lipid profile in patients with CKD, dialysis, and renal transplant recipients are complex because there are profound changes in the structure and function of lipoprotein and lipid molecules, which lead to accelerated atherosclerosis, cardiovascular disease and stroke. Cardiovascular disease and stroke are the major cause of morbidity and mortality in patients with impaired renal function. In this review, the pathogenesis and treatment of CKD-induced dyslipidemia are discussed. Studies on lipid abnormalities in predialysis, hemodialysis and peritoneal dialysis patients are analyzed. In addition, results of the studies that tested the effects of hypolipidemic drugs on stroke morbidity and mortality in patients with CKD are reported.
authors.forename: Petar
authors.initials: P
authors.lastname: Kes
authors.forename: Vanja
authors.initials: V
authors.lastname: Bašić-Kes
authors.forename: Vesna
authors.initials: V
authors.lastname: Furic-Cunko
authors.forename: Ines
authors.initials: I
authors.lastname: Mesar
authors.forename: Nikolina
authors.initials: N
authors.lastname: Bašić-Jukić
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology; D050171:Dyslipidemias / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects; D010530:Peritoneal Dialysis / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control